FibroGen, Inc. logo

FibroGen, Inc.

NASDAQ:FGEN

Overview | Financials
Company Name FibroGen, Inc.
Symbol FGEN
Currency USD
Price 0.579
Market Cap 58,345,830
Dividend Yield 0%
52-week-range 0.18 - 2.93
Industry Biotechnology
Sector Healthcare
CEO Mr. Thane Wettig
Website https://www.fibrogen.com

An error occurred while fetching data.

About FibroGen, Inc.

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the

Related Stocks

Kura Oncology, Inc. logo

Kura Oncology, Inc.

KURA

8.98 USD

Cutera, Inc. logo

Cutera, Inc.

CUTR

0.319 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

2.915 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

6 USD

Avid Bioservices, Inc. logo

Avid Bioservices, Inc.

CDMO

12.28 USD

Phibro Animal Health Corporation logo

Phibro Animal Health Corporation

PAHC

21.68 USD

Sana Biotechnology, Inc. logo

Sana Biotechnology, Inc.

SANA

1.7 USD

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

42.03 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

12.925 USD

ImmunoGen, Inc. logo

ImmunoGen, Inc.

IMGN

31.235 USD

Financials

Numbers are in millions USD

Numbers are in millions USD